Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Sibaud

Showing results (41-50 of 137) with videos related to

Pageof 14
Sort By:
JAAD Case Reports|April 5, 2021
Anti-programmed cell death protein 1-induced lichenoid changes of the nail unit: Histopathologic descriptionClaire van Damme, Vincent Sibaud, Josette André, et al.
Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology|October 29, 2011
CosmeceutiQoL: a tool for assessing dermo-cosmetic products' impact on quality of lifeCharles Taieb, Nora Rahhali, Valentin Moingeon, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 8, 2026
Optimized management of enfortumab vedotin-related dermatological toxicityEstelle Parriel, Anouk Perego-Langlais, Saskia Ingen-Housz-Oro, et al.
Acta Dermato-Venereologica|April 9, 2014
A new ten-item questionnaire for assessing sensitive skin: the Sensitive Scale-10Laurent Misery, Catherine Jean-Decoster, Sophie Mery, et al.
Journal for Immunotherapy of Cancer|November 18, 2018
Immune checkpoint inhibitor-related acral vasculitisThibault Comont, Vincent Sibaud, Loïc Mourey, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 30, 2020
Balancing Cancer Immunotherapy Efficacy and ToxicityDouglas B Johnson, Baruch D Jakubovic, Vincent Sibaud, et al.
Journal of the American Academy of Dermatology|July 22, 2024
Evaluation of anticancer therapy-related dermatologic adverse events: Insights from Food and Drug Administration's Adverse Event Reporting System datasetSamir Salah, Delphine Kerob, Cecile Pages Laurent, et al.
JAMA Dermatology|May 25, 2017
Severe Onycholysis and Eyelash Trichomegaly Following Use of New Selective Pan-FGFR InhibitorsSarah Bétrian, Carlos Gomez-Roca, Emmanuelle Vigarios, et al.
Journal of the American Academy of Dermatology|September 19, 2017
Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysisJulia Dai, Viswanath R Belum, Shenhong Wu, et al.
International Journal of Dermatology|September 28, 2017
Oral lesions of acute generalized exanthematous pustulosisEmmanuelle Vigarios, Emilie Tournier, Damien Pouessel, et al.
Pageof 14

Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
JAAD Case Reports|April 5, 2021
Anti-programmed cell death protein 1-induced lichenoid changes of the nail unit: Histopathologic descriptionClaire van Damme, Vincent Sibaud, Josette André, et al.
Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology|October 29, 2011
CosmeceutiQoL: a tool for assessing dermo-cosmetic products' impact on quality of lifeCharles Taieb, Nora Rahhali, Valentin Moingeon, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 8, 2026
Optimized management of enfortumab vedotin-related dermatological toxicityEstelle Parriel, Anouk Perego-Langlais, Saskia Ingen-Housz-Oro, et al.
Acta Dermato-Venereologica|April 9, 2014
A new ten-item questionnaire for assessing sensitive skin: the Sensitive Scale-10Laurent Misery, Catherine Jean-Decoster, Sophie Mery, et al.
Journal for Immunotherapy of Cancer|November 18, 2018
Immune checkpoint inhibitor-related acral vasculitisThibault Comont, Vincent Sibaud, Loïc Mourey, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 30, 2020
Balancing Cancer Immunotherapy Efficacy and ToxicityDouglas B Johnson, Baruch D Jakubovic, Vincent Sibaud, et al.
Journal of the American Academy of Dermatology|July 22, 2024
Evaluation of anticancer therapy-related dermatologic adverse events: Insights from Food and Drug Administration's Adverse Event Reporting System datasetSamir Salah, Delphine Kerob, Cecile Pages Laurent, et al.
JAMA Dermatology|May 25, 2017
Severe Onycholysis and Eyelash Trichomegaly Following Use of New Selective Pan-FGFR InhibitorsSarah Bétrian, Carlos Gomez-Roca, Emmanuelle Vigarios, et al.
Journal of the American Academy of Dermatology|September 19, 2017
Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysisJulia Dai, Viswanath R Belum, Shenhong Wu, et al.
International Journal of Dermatology|September 28, 2017
Oral lesions of acute generalized exanthematous pustulosisEmmanuelle Vigarios, Emilie Tournier, Damien Pouessel, et al.
Pageof 14